No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US OptionsDetailed Quotes
ZIMV250117C22500
- 0.29
- 0.000.00%
15min DelayClose Dec 20 16:00 ET
0.00High0.00Low
0.29Open0.29Pre Close0 Volume635 Open Interest22.50Strike Price0.00Turnover144.37%IV67.57%PremiumJan 17, 2025Expiry Date0.00Intrinsic Value100Multiplier25DDays to Expiry0.29Extrinsic Value100Contract SizeAmericanOptions Type0.1305Delta0.0410Gamma46.90Leverage Ratio-0.0216Theta0.0010Rho6.12Eff Leverage0.0076Vega
Intraday
- 5D
- Daily
News
BioAge Labs, Riot Platforms And Other Big Stocks Moving Lower In Monday's Pre-Market Session
ZimVie Inc (ZIMV) Gets a Sell From Barclays
Earnings Call: ZimVie Reports Steady Growth and Improved Margins in Q3
Needham Maintains ZimVie(ZIMV.US) With Buy Rating, Maintains Target Price $23
ZimVie (ZIMV) Q3 2024 Earnings Call Transcript
ZimVie Inc. (ZIMV) Q3 2024 Earnings Call Transcript Summary